These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31943621)

  • 21. Treatment with allopurinol decreases the number of acute gout attacks despite persistently elevated serum uric acid levels.
    Beutler AM; Rull M; Schlesinger N; Baker DG; Hoffman BI; Schumacher HR
    Clin Exp Rheumatol; 2001; 19(5):595. PubMed ID: 11579724
    [No Abstract]   [Full Text] [Related]  

  • 22. An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population.
    Robinson PC; Taylor WJ; Dalbeth N
    J Rheumatol; 2015 Sep; 42(9):1702-7. PubMed ID: 26233513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physician adherence to ACR gout treatment guidelines: perception versus practice.
    Oderda GM; Shiozawa A; Walsh M; Hess K; Brixner DI; Feehan M; Akhras K
    Postgrad Med; 2014 May; 126(3):257-67. PubMed ID: 24918810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal arthritis: a new 'package of care' strategy for effective gout management.
    Dalbeth N
    Nat Rev Rheumatol; 2012 Sep; 8(9):507-8. PubMed ID: 22847469
    [No Abstract]   [Full Text] [Related]  

  • 25. A survey of the assessment and management of gout in general practitioners and medical officers within the Illawarra Network, Australia.
    Terrill M; Riordan J
    Int J Rheum Dis; 2017 Aug; 20(8):990-995. PubMed ID: 27153502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current and future therapies for gout.
    Pascart T; Richette P
    Expert Opin Pharmacother; 2017 Aug; 18(12):1201-1211. PubMed ID: 28689430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of gout in the real world: current practice versus guideline recommendations.
    Doghramji PP; Fermer S; Wood R; Morlock R; Baumgartner S
    Postgrad Med; 2016 Jan; 128(1):106-14. PubMed ID: 26592538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice.
    Cottrell E; Crabtree V; Edwards JJ; Roddy E
    BMC Fam Pract; 2013 Nov; 14():170. PubMed ID: 24225170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adherence to urate-lowering therapy.
    Day RO
    South Med J; 2009 Jan; 102(1):114-5. PubMed ID: 19077754
    [No Abstract]   [Full Text] [Related]  

  • 30. Monitoring of Urate-Lowering Therapy Among US Veterans Following the 2012 American College of Rheumatology Guidelines for Management of Gout.
    Hughes JC; Wallace JL; Bryant CL; Salvig BE; Fourakre TN; Stone WJ
    Ann Pharmacother; 2017 Apr; 51(4):301-306. PubMed ID: 27881692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GOSPEL 3: Management of gout by primary-care physicians and office-based rheumatologists in France in the early 21st century - comparison with 2006 EULAR Recommendations.
    Goossens J; Lancrenon S; Lanz S; Ea HK; Lambert C; Guggenbuhl P; Saraux A; Delva C; Sahbane S; Lioté F
    Joint Bone Spine; 2017 Jul; 84(4):447-453. PubMed ID: 28411137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gout - a treatable condition].
    Johannsdottir GA; Palsson O; Jonsson H; Gudbjornsson B
    Laeknabladid; 2018 Apr; 104(4):177-186. PubMed ID: 29616658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved management of acute gout during hospitalization following introduction of a protocol.
    Kamalaraj N; Gnanenthiran SR; Kathirgamanathan T; Hassett GM; Gibson KA; McNeil HP
    Int J Rheum Dis; 2012 Dec; 15(6):512-20. PubMed ID: 23253233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel uricosurics.
    Bardin T; Richette P
    Rheumatology (Oxford); 2018 Jan; 57(suppl_1):i42-i46. PubMed ID: 29272511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyperuricemia and gout: therapeutic indications].
    Pawlotsky Y
    Rev Prat; 1994 Jan; 44(2):206-9. PubMed ID: 8178077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting Response or Non-response to Urate-Lowering Therapy in Patients with Gout.
    Graham GG; Stocker SL; Kannangara DRW; Day RO
    Curr Rheumatol Rep; 2018 Jun; 20(8):47. PubMed ID: 29931553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient Perceptions of Gout Management Goals: A Cross-sectional Internet Survey.
    Singh JA; Edwards NL
    J Clin Rheumatol; 2020 Jun; 26(4):129-133. PubMed ID: 32453285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review: Gout: A Roadmap to Approaches for Improving Global Outcomes.
    Dalbeth N; Choi HK; Terkeltaub R
    Arthritis Rheumatol; 2017 Jan; 69(1):22-34. PubMed ID: 27389665
    [No Abstract]   [Full Text] [Related]  

  • 39. Recurrent Gout and Serum Urate.
    Shan D
    JAMA; 2024 May; 331(20):1767-1768. PubMed ID: 38696164
    [No Abstract]   [Full Text] [Related]  

  • 40. Does starting allopurinol prolong acute treated gout? A randomized clinical trial.
    Hill EM; Sky K; Sit M; Collamer A; Higgs J
    J Clin Rheumatol; 2015 Apr; 21(3):120-5. PubMed ID: 25807090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.